{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:38:59Z","timestamp":1790602739779,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-025-08562-7","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:14:35Z","timestamp":1743394475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metformin use and risk of total joint replacement in patients with diabetes: a longitudinal cohort study of Alberta\u2019s Tomorrow Project"],"prefix":"10.1186","volume":"26","author":[{"given":"Ming","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Vena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Shen-Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean T.","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"issue":"1","key":"8562_CR1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/1573399812666151123104352","volume":"13","author":"FC Aiello","year":"2017","unstructured":"Aiello FC, Trovato FM, Szychlinska MA, Imbesi R, Castrogiovanni P, Loreto C, Musumeci G. Molecular links between diabetes and osteoarthritis: the role of physical activity. Curr Diabetes Rev. 2017;13(1):50\u20138.","journal-title":"Curr Diabetes Rev"},{"key":"8562_CR2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diabres.2016.10.021","volume":"122","author":"A Courties","year":"2016","unstructured":"Courties A, Sellam J. Osteoarthritis and type 2 diabetes mellitus: what are the links? Diabetes Res Clin Pract. 2016;122:198\u2013206.","journal-title":"Diabetes Res Clin Pract"},{"issue":"35","key":"8562_CR3","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1074\/jbc.M117.802157","volume":"292","author":"C Vaamonde-Garcia","year":"2017","unstructured":"Vaamonde-Garcia C, Courties A, Pigenet A, Laiguillon MC, Sautet A, Houard X, Kerdine-Romer S, Meijide R, Berenbaum F, Sellam J. The nuclear factor-erythroid 2-related factor\/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis. J Biol Chem. 2017;292(35):14505\u201315.","journal-title":"J Biol Chem"},{"issue":"1","key":"8562_CR4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00125-007-0873-z","volume":"51","author":"DM Nathan","year":"2008","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the Thiazolidinediones. Diabetologia. 2008;51(1):8\u201311.","journal-title":"Diabetologia"},{"issue":"1","key":"8562_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4049\/jimmunol.1800006","volume":"203","author":"MJ Park","year":"2019","unstructured":"Park MJ, Moon SJ, Baek JA, Lee EJ, Jung KA, Kim EK, Kim DS, Lee JH, Kwok SK, Min JK, et al. Metformin augments Anti-Inflammatory and chondroprotective properties of mesenchymal stem cells in experimental osteoarthritis. J Immunol. 2019;203(1):127\u201336.","journal-title":"J Immunol"},{"issue":"10","key":"8562_CR6","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2337\/dc18-2356","volume":"42","author":"C Sardu","year":"2019","unstructured":"Sardu C, Paolisso P, Sacra C, Mauro C, Minicucci F, Portoghese M, Rizzo MR, Barbieri M, Sasso FC, D\u2019Onofrio N, et al. Effects of Metformin therapy on coronary endothelial dysfunction in patients with prediabetes with stable angina and nonobstructive coronary artery stenosis: the CODYCE multicenter prospective study. Diabetes Care. 2019;42(10):1946\u201355.","journal-title":"Diabetes Care"},{"issue":"19","key":"8562_CR7","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1111\/jcmm.17519","volume":"26","author":"Y Bu","year":"2022","unstructured":"Bu Y, Peng M, Tang X, Xu X, Wu Y, Chen AF, Yang X. Protective effects of Metformin in various cardiovascular diseases: clinical evidence and AMPK-dependent mechanisms. J Cell Mol Med. 2022;26(19):4886\u2013903.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"8562_CR8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000327151","volume":"1","author":"D Klachko","year":"2011","unstructured":"Klachko D, Whaley-Connell A. Use of Metformin in patients with kidney and cardiovascular diseases. Cardiorenal Med. 2011;1(2):87\u201395.","journal-title":"Cardiorenal Med"},{"issue":"6","key":"8562_CR9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acsptsci.1c00167","volume":"4","author":"M Ala","year":"2021","unstructured":"Ala M, Ala M. Metformin for cardiovascular protection, inflammatory bowel disease, osteoporosis, periodontitis, polycystic ovarian syndrome, neurodegeneration, cancer, inflammation and senescence: what is next?? ACS Pharmacol Transl Sci. 2021;4(6):1747\u201370.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"5","key":"8562_CR10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","volume":"119","author":"AR Cameron","year":"2016","unstructured":"Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, McNeilly AD, Balfour DJ, Savinko T, Wong AK, et al. Anti-Inflammatory effects of Metformin irrespective of diabetes status. Circ Res. 2016;119(5):652\u201365.","journal-title":"Circ Res"},{"issue":"1","key":"8562_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3904\/kjim.2021.363","volume":"37","author":"JW Kim","year":"2022","unstructured":"Kim JW, Choe JY, Park SH. Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease. Korean J Intern Med. 2022;37(1):13\u201326.","journal-title":"Korean J Intern Med"},{"key":"8562_CR12","doi-asserted-by":"crossref","first-page":"109230","DOI":"10.1016\/j.intimp.2022.109230","volume":"112","author":"W Wanchaitanawong","year":"2022","unstructured":"Wanchaitanawong W, Thinrungroj N, Chattipakorn SC, Chattipakorn N, Shinlapawittayatorn K. Repurposing Metformin as a potential treatment for inflammatory bowel disease: evidence from cell to the clinic. Int Immunopharmacol. 2022;112:109230.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"8562_CR13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.joca.2022.05.005","volume":"30","author":"YZ Lim","year":"2022","unstructured":"Lim YZ, Wang Y, Estee M, Abidi J, Udaya Kumar M, Hussain SM, Wluka AE, Little CB, Cicuttini FM. Metformin as a potential disease-modifying drug in osteoarthritis: a systematic review of pre-clinical and human studies. Osteoarthritis Cartilage. 2022;30(11):1434\u201342.","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"8562_CR14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/iep.12230","volume":"98","author":"B Poulet","year":"2017","unstructured":"Poulet B. Models to define the stages of articular cartilage degradation in osteoarthritis development. Int J Exp Pathol. 2017;98(3):120\u20136.","journal-title":"Int J Exp Pathol"},{"issue":"2","key":"8562_CR15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/BOR.0000000000000923","volume":"35","author":"AJ Knights","year":"2023","unstructured":"Knights AJ, Redding SJ, Maerz T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr Opin Rheumatol. 2023;35(2):128\u201334.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"8562_CR16","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1038\/s41598-022-15871-7","volume":"12","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Yip BHK, Hunter DJ, Rabago DP, Mallen CD, Yeoh EK, Wong SYS, Sit RW. Metformin use and the risk of total knee replacement among diabetic patients: a propensity-score-matched retrospective cohort study. Sci Rep. 2022;12(1):11571.","journal-title":"Sci Rep"},{"issue":"49","key":"8562_CR17","doi-asserted-by":"crossref","first-page":"E1672","DOI":"10.1503\/cmaj.220952","volume":"194","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Huang JY, Ruan G, Cao P, Chen S, Zhang Y, Han W, Chen T, Cai X, Liu J, et al. Metformin use and associated risk of total joint replacement in patients with type 2 diabetes: a population-based matched cohort study. CMAJ: Can Med Association J = J De l\u2019Association Medicale Canadienne. 2022;194(49):E1672\u201384.","journal-title":"CMAJ: Can Med Association J = J De l\u2019Association Medicale Canadienne"},{"issue":"1","key":"8562_CR18","doi-asserted-by":"crossref","first-page":"e0191242","DOI":"10.1371\/journal.pone.0191242","volume":"13","author":"CH Lu","year":"2018","unstructured":"Lu CH, Chung CH, Lee CH, Hsieh CH, Hung YJ, Lin FH, Tsao CH, Hsieh PS, Chien WC. Combination COX-2 inhibitor and Metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan. PLoS ONE. 2018;13(1):e0191242.","journal-title":"PLoS ONE"},{"issue":"1","key":"8562_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13075-019-1915-x","volume":"21","author":"Y Wang","year":"2019","unstructured":"Wang Y, Hussain SM, Wluka AE, Lim YZ, Abram F, Pelletier JP, Martel-Pelletier J, Cicuttini FM. Association between Metformin use and disease progression in obese people with knee osteoarthritis: data from the osteoarthritis Initiative-a prospective cohort study. Arthritis Res Ther. 2019;21(1):127.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8562_CR20","doi-asserted-by":"crossref","first-page":"e233646","DOI":"10.1001\/jamanetworkopen.2023.3646","volume":"6","author":"MC Baker","year":"2023","unstructured":"Baker MC, Sheth K, Liu Y, Lu D, Lu R, Robinson WH. Development of osteoarthritis in adults with type 2 diabetes treated with Metformin vs a sulfonylurea. JAMA Netw Open. 2023;6(3):e233646.","journal-title":"JAMA Netw Open"},{"key":"8562_CR21","doi-asserted-by":"crossref","unstructured":"Ye M, Robson PJ, Eurich DT, Vena JE, Xu JY, Johnson JA. Cohort Profile: Alberta\u2019s Tomorrow Project. Int J Epidemiol 2016.","DOI":"10.1093\/ije\/dyw256"},{"key":"8562_CR22","unstructured":"Public Health Agency of Canada: Report from the National Diabetes Surveillance System: Diabetes in Canada. 2009. In.; 2009."},{"key":"8562_CR23","doi-asserted-by":"crossref","unstructured":"Mathe N, Ryan A, Cook A, Sargious P, Senior P, Johnson JA, Yeung RO. Enhancing diabetes surveillance across Alberta by adding laboratory and pharmacy data to the National diabetes surveillance system methods. Can J Diabetes 2021.","DOI":"10.1016\/j.jcjd.2021.12.001"},{"key":"8562_CR24","unstructured":"CJRR annual report. Hip and knee replacements in Canada. In. Edited by CIHI; 2022."},{"issue":"5","key":"8562_CR25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcjd.2018.12.001","volume":"43","author":"M Eskin","year":"2019","unstructured":"Eskin M, Simpson SH, Eurich DT. Evaluation of healthy user effects with Metformin and other oral antihyperglycemia medication users in adult patients with type 2 diabetes. Can J Diabetes. 2019;43(5):322\u20138.","journal-title":"Can J Diabetes"},{"issue":"1","key":"8562_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"ES Johnson","year":"2013","unstructured":"Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, et al. The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2013;22(1):1\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"8562_CR27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bcp.12705","volume":"80","author":"JL Faillie","year":"2015","unstructured":"Faillie JL. Indication bias or protopathic bias? Br J Clin Pharmacol. 2015;80(4):779\u201380.","journal-title":"Br J Clin Pharmacol"},{"key":"8562_CR28","unstructured":"Armitage PBG, Matthews J. J: Statistical methods in medical research. Wiley; 2008."},{"issue":"29","key":"8562_CR29","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1002\/sim.5452","volume":"31","author":"PC Austin","year":"2012","unstructured":"Austin PC. Generating survival times to simulate Cox proportional hazards models with time-varying covariates. Stat Med. 2012;31(29):3946\u201358.","journal-title":"Stat Med"},{"key":"8562_CR30","volume-title":"Analysis of survival data","author":"DR Cox","year":"1984","unstructured":"Cox DR, Oakes D. Analysis of survival data. New York: Chapman & Hall; 1984."},{"key":"8562_CR31","doi-asserted-by":"crossref","first-page":"j4587","DOI":"10.1136\/bmj.j4587","volume":"359","author":"MA Mansournia","year":"2017","unstructured":"Mansournia MA, Etminan M, Danaei G, Kaufman JS, Collins G. Handling time varying confounding in observational research. BMJ. 2017;359:j4587.","journal-title":"BMJ"},{"issue":"5 Suppl Guideli","key":"8562_CR32","first-page":"S265","volume":"51","author":"AF Brown","year":"2003","unstructured":"Brown AF, Mangione CM, Saliba D, Sarkisian CA, California Healthcare Foundation\/American Geriatrics Society Panel on Improving Care for Elders with D. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265\u2013280.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"8562_CR33","first-page":"41","volume":"20","author":"D Garriguet","year":"2009","unstructured":"Garriguet D. Diet quality in Canada. Health Rep. 2009;20(3):41\u201352.","journal-title":"Health Rep"},{"key":"8562_CR34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ypmed.2017.06.009","volume":"101","author":"NM Solbak","year":"2017","unstructured":"Solbak NM, Xu JY, Vena JE, Csizmadi I, Whelan HK, Robson PJ. Diet quality is associated with reduced incidence of cancer and self-reported chronic disease: observations from Alberta\u2019s tomorrow project. Prev Med. 2017;101:178\u201387.","journal-title":"Prev Med"},{"issue":"1","key":"8562_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327.","journal-title":"Med Care"},{"issue":"11","key":"8562_CR36","first-page":"721","volume":"18","author":"HY Chang","year":"2012","unstructured":"Chang HY, Weiner JP, Richards TM, Bleich SN, Segal JB. Validating the adapted diabetes complications severity index in claims data. Am J Manag Care. 2012;18(11):721\u20136.","journal-title":"Am J Manag Care"},{"issue":"10","key":"8562_CR37","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/acr.22612","volume":"67","author":"DA Marshall","year":"2015","unstructured":"Marshall DA, Vanderby S, Barnabe C, MacDonald KV, Maxwell C, Mosher D, Wasylak T, Lix L, Enns E, Frank C, et al. Estimating the burden of osteoarthritis to plan for the future. Arthritis Care Res (Hoboken). 2015;67(10):1379\u201386.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"8562_CR38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.joca.2012.12.008","volume":"21","author":"MH Gillam","year":"2013","unstructured":"Gillam MH, Lie SA, Salter A, Furnes O, Graves SE, Havelin LI, Ryan P. The progression of end-stage osteoarthritis: analysis of data from the Australian and Norwegian joint replacement registries using a multi-state model. Osteoarthritis Cartilage. 2013;21(3):405\u201312.","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"8562_CR39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research G. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J Med. 2002;346(6):393\u2013403.","journal-title":"N Engl J Med"},{"key":"8562_CR40","doi-asserted-by":"crossref","unstructured":"Livesey G, Taylor R, Livesey HF, Buyken AE, Jenkins DJA, Augustin LSA, Sievenpiper JL, Barclay AW, Liu S, Wolever TMS et al. Dietary glycemic index and load and the risk of type 2 diabetes: assessment of causal relations. Nutrients 2019, 11(6).","DOI":"10.3390\/nu11061436"},{"issue":"6","key":"8562_CR41","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.arth.2020.01.057","volume":"35","author":"PA Richey","year":"2020","unstructured":"Richey PA, Johnson KC, Neiberg RH, Bahnson JL, Singhal K, Coday M, Thomas F, Lewis CE, Mihalko WM, Look ARG. Association of the intensive lifestyle intervention with total knee replacement in the look AHEAD (Action for health in Diabetes) clinical trial. J Arthroplasty. 2020;35(6):1576\u201382.","journal-title":"J Arthroplasty"},{"issue":"4","key":"8562_CR42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00296-009-1183-1","volume":"30","author":"AC Bay-Jensen","year":"2010","unstructured":"Bay-Jensen AC, Hoegh-Madsen S, Dam E, Henriksen K, Sondergaard BC, Pastoureau P, Qvist P, Karsdal MA. Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis? Rheumatol Int. 2010;30(4):435\u201342.","journal-title":"Rheumatol Int"},{"key":"8562_CR43","doi-asserted-by":"crossref","unstructured":"Ronn K, Reischl N, Gautier E, Jacobi M. Current surgical treatment of knee osteoarthritis. Arthritis 2011, 2011:454873.","DOI":"10.1155\/2011\/454873"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-08562-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:15:49Z","timestamp":1743394549000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-08562-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8562"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-08562-7","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health Research Ethics Board (HREB) of the University of Alberta (study ID Pro00058561). This study is in compliance with the Declaration of Helsinki to protect human participants in our research. All participants of this study provided valid written consent for data linkage with administrative healthcare and other health-related data. The storage, use and disposition of participants\u2019 data in this study complies with the Personal Information Protection and Electronic Documents Act (PIPEDA) in Canada.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"All participants of this study had provided valid written consent for data linkage with administrative healthcare and other health-related data for research purposes, and informed consent to participate was obtained from all of the participants in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"312"}}